NightHawk Biosciences Provides Second Quarter 2022 Business Update - Seite 3
DURHAM, N.C., Aug. 10, 2022 (GLOBE NEWSWIRE) - NightHawk Biosciences (NYSE American: NHWK), a fully-integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today provided strategic, …